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Liver and kidney commonly affected by diabetes in chronic cases but pathogenetic mechanisms are not fully understood in early
stages of the disease. The aim of this study was to investigate the immunohistochemical expression of caspase-3, cyclooxygenase
(COX)-1 and-2, calcium sensing receptor (CSR), and hypoxia inducible factor-1α (HIF-1α) in pancreas, liver, and kidney in
streptozotocin (STZ) induced DM. Study group (n = 6) were received streptozotocin (50 mg/kg) and control group (n = 6)
physiologic saline. The blood glucose and ketonuria were measured, and necropsy was performed on them on third, fourth,
and fifth days. Immunohistochemistry revealed that marked increase in caspase-3 reaction pancreas, liver, and kidney in the study
group than control group. COX-1 slightly increased in these organs in study group compared to controls. Immunohistochemically
COX-2 reaction was markedly positive in liver and kidney, but slightly increased in pancreas. The most increased reaction was
observed in CRS and all organs were markedly positive. HIF-1α expression was also increased but the reaction was more severe in
pancreas than liver and kidney. This study indicated that degeneration starts in organs in early stages of the disease and the most
effective route for degeneration related to increase of calcium influx and hypoxia upon cells in DM.
1. Introduction
Diabetes mellitus is a metabolic disorder that results from
a reduction of insulin available for normal function of
many cells in the body. In some cases, increased concentra-
tions of glucagon contribute to development of persistent
hyperglycemia. In addition to chronic hyperglycemia, DM is
characterized by disturbance of carbohydrate, fat, and pro-
tein metabolism resulting from defects in insulin secretion,
insulin action, or both. The diseases can also be recognized
during less overt stages, most usually by the presence of
glucose intolerance. The effects of DM include long-term
damage, dysfunction, and failure of various organs, espe-
cially the eyes, kidneys, livers, hearts, and blood vessels [1].
In the pathogenesis of DM, several factors are responsible
for the decreased availability of insulin. Hyperglycemia, and
its attendant effects upon cells, underlies the pathogenic
lesions of DM [2]. Cellular damages can be demonstrated by
numerous markers by immunohistochemistry. For example,
caspases are a family of cysteine proteases mainly involved in
the apoptotic pathway [3]. Caspase-3 is one of the effector
caspases that has been implicated as a key protease cleaving
multiple cellular substrates, including components related to
DNA repair and regulation, to bring the cell to its demise
[4, 5]. Cyclooxygenase enzymes also play an important
role at cellular damages. Three different COX enzymes
existed, now known as COX-1, COX-2, and COX-3, they are
responsible for formation of important biological mediators
called prostanoids, including prostaglandins, prostacyclin,
and thromboxane. Pharmacological inhibition of COX can
provide relief from the symptoms of inflammation and
pain [6]. In diabetes, direct evidence that cytoplasmic Ca2+
triggers exocytosis of the insulin granules is obtained from
experiments using β cell of which the plasma membrane is
permeabilized in these cells, the membrane potential is dissi-
pate and the cytosolic concentration of small molecules can
be controlled [7]. Calcium sensing receptor is a G protein-
coupled receptor (GPCR) and regulation of extracellular and
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intracellular calcium homeostasis related to CSR. It has also
been found in a wide variety of organs not involved in
systemic calcium homeostasis that it plays important roles
in cellular damages [8–10]. Hypoxia-inducible factor-1α has
central role in degeneration and a transcriptional activator
that promotes angiogenesis [11, 12]. HIF-1α expression is
also induced under normoxic conditions when cells are
stimulated with growth factors, inflammatory cytokines,
lactate, or prostaglandins [13–15].
DM is a complex disease and causes numerous cellular
damages in different organs. A number of pathogenetic
advances have been made during the past decade but numer-
ous mechanisms need to be clarified. The pathogenetic
mechanisms are likely interactive and linked in DM. For
that reason, mechanism of cellular damage is not fully
understood. This preliminary study was designed to explore
the cellular distribution and the underlying mechanisms of
hypoxia and calcium influx in experimental diabetes.
2. Material and Methods
Twelve female Sprague-Dawley rats, weighing 125 to 150 g
and aged 2 months, were maintained at the Experimental
Animal Housing Unit of the University of Akdeniz. They
were randomly allocated into 2 groups, as follows: study
group that treated with STZ and control group. Both groups
were composed of 6 rats and were allowed free access to
water and food. Rats were fasted before the STZ injection.
A single intraperitoneal injection of 50 mg/kg STZ (Sigma
Chemical Co, St. Louis, Mo) dissolved immediately before
administration in freshly prepared 50 mmol/L citrate buffer
(pH 4.0) that was given on day 0. Control animals received an
equivalent volume of physiologic saline. Urine samples were
collected at 3rd, 4th, and 5th days. At the third day, two rats
form, study group and two rats from the control group were
anesthetized with ether before blood and tissue samples were
obtained. The blood glucose concentration was measured in
blood from jugular vein in the morning from 2 rats in each
group before euthanasia, and then necropsy was performed
on them after the third day. The MS9 blood counting equip-
ment was used for hematological analysis of the blood drawn
in EDTA tubes. Glucose levels were analyzed in serum sam-
ples using IDEXX VetTest equipment and reagents. Pancreas,
liver, and kidney tissue samples were collected and fixed
in 10% buffered formalin. After routine procedure, tissues
were blocked in paraffin and cut to 5 μm thickness. Tissue
sections were stained with hematoxylin-eosin (HE) and
examined microscopically. Afterward, pancreas, liver, and
kidney samples were immunostained with caspase-3 (rabbit
polyclonal, Cat. no. 250573, Abbiotec-San Diego, USA),
COX-1 (Epitope Specific rabbit antibody, Cat. no. RR-10687-
P0, Thermo scientific, Fremont, USA), COX-2 (Cat. no: RM-
9121-S0, Thermo scientific, Fremont, USA), CSR (Rb pAb
to CSR, ab62653-100, Abcam Lot: 433372, Cambridge, UK),
and HIF-1α (H1α67, Sc-53546, Santa Cruz Biotechnology
Inc. CA, USA) according to the manufactures’ instructions.
In this study, avidin-biotin complex peroxidase (ABC-
P) method was used for immunohistochemistry. Paraffin
Table 1: Blood and urine values of the rats in groups.
Study group Blood glucose (mmol/L) Ketonuria
3rd day 10.15± 2.18 —
4th day 11.84± 1.84 +
5th day 9.91± 1.69 +
Control group
3rd day 4.05± 1.42 —
4th day 5.67± 0.94 —
5th day 6.07± 0.86 —
Reference values 2.28–7.50 —
The differences between the means of groups are statistically significant
(P < 0.05).
blocks were sectioned at 5 μm for immunohistochemical
examination, and sections were attached to glass slides coated
with poly-L-lysine. The slides were dried overnight at 37◦C
to optimize adhesion. Sections were deparaffinized through
xylene, and tissues were rehydrated in sequentially graduated
ethyl alcohol. Slides were incubated in hydrogen peroxide
in methanol for 10 min to reduce nonspecific background
staining due to endogenous peroxidase. The sections were
washed twice, in phosphate buffer solution (PBS). Then,
tissues were boiled in 1 : 100 citrate buffer solution for10
min and cooled for 20 min. The cooled tissues were washed
four times in PBS prior to application of blocking serum
for 5 min. Then, primary antibody was applied; tissues were
incubated for 30 min at room temperature. They were rinsed
4 times in PBS, given an application of biotinylated anti-
polyvalent antibody and incubated for 10 min at room tem-
perature. After being washed three times in PBS, streptavidin
peroxidase was applied and the samples were incubated for
10 min at room temperature, and then rinsed 4 times in
PBS. Tissues were further incubated for 20 min at room
temperature in a solution of DAB (3, 30 diaminobenzidine)
chromogen. After being washed in PBS, tissues were counter
stained with Mayer’s haematoxylin, washed in water, and
coverslips were applied with mounting media. For negative
control, primary antibody was not added to the sections.
In order to evaluate the percentage of immunopositive
cells, 100 cells calculated in 10 different microscopic high-
powered fields of each slide were examined under the 40x
objective of a trinocular microscope (Nikon E600) and
microphotography apparatus. The count of positive cells one
high-power field for each marker was noted and compared
with control groups.
In the statistical evaluations, Students t test was used.
Calculations were made using the SPSS 13.0 program pack.
P < 0.05 was accepted as statistically significant.
3. Results
Hyperglycemia and ketonuria was initially observed in both
rats in study group 3 days after administration. There
were no glucosuria and ketonuria in the control group.
Biochemical results of blood and urine were shown in
Table 1. No macroscopical changes were observed in organs
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Figure 1: Caspase-3 reactions. (a) Immunopositive reaction in Langerhans islets cells (arrows) in study group, Bar = 50 μm; (b) no
immunoreaction in control group, Bar = 50 μm; (c) marked reaction in hepatocytes in study group (arrows), Bar = 100 μm. (d) Slight
immunoreaction in some hepatocytes (arrows) in control group, Bar = 50 μm; (e) Strong reactions in tubular cells in kidney (arrows), Bar =
100 μm. (f) A few immunopositive cells in kidney in control group, Bar = 100 μm. ABC-P method with Hematoxyline counterstaining were
used for all tissue. The right column belongs to study group and left column belongs to control group.
in both groups. At the histopathological examination of
pancreas, degenerative and necrotic beta cells were seen in
Langerhans islets in study group. At microscopical examina-
tion slight degenerative changes were observed in liver and
tubular epithelial cells of the kidney. Immunohistochemical
observation of caspase-3, COX-1, COX-2, CSR, and HIF-
1α immunostained sections revealed severe damage in these
organs in early stages of the DM. Statistical results of
immunohistochemical observation were shown in graphic.
Caspase-3 immunopositive cell numbers were markedly
increased in pancreatic islets in study group. In addition to
pancreas, caspase-3 immunopositive reaction was higher in
liver hepatocyte in study group than controls and strong
immunoreactions were observed in kidney tubular epithelial
cells (Figures 1(a), 1(b), 1(c), 1(d), 1(e), and 1(f)). Slight
increases in COX-1 reaction were observed in pancreas, liver,
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Figure 2: COX-2 reactions. (a) Severe positive immunoreaction in endocrine islets of pancreas in study group (arrows), Bar = 50 μm. (b)
No immunoreaction in Langerhans islets of pancreas in control group, Bar = 100 μm. (c) Moderate immunoreaction in hepatocyte in study
group (arrows), Bar = 100 μm. (d) A few immunoreactions in liver (arrows) in control group, Bar = 50 μm. (e) Strong immunopositive
reaction in nonmacula densa area in kidney (arrows) in study group, Bar = 100 μm. (f) A few immunoreactions in kidney tubul cells in
macula densa (arrows) in control group, Bar = 100 μm. ABC-P method with hematoxylin counterstaining was used for all tissues. The right
column belongs to study group and left column is belong to control group.
and kidney in study group’s rats. In kidneys, immunohisto-
chemical examination revealed that the expression of COX-
1 localized on collecting tubules. COX-2 immunoreactive
cells were markedly increased in study rats compared with
controls in all examined organs. In control group, COX-
2 positive immunostaining was observed in individual
kidney tubular epithelial cells. Marked immunopositivity
was demonstrated in macula densa and nonmacula densa
tubules of kidney in study group (Figures 2(a), 2(b), 2(c),
2(d), 2(e), and 2(f)). In both groups, CSR immunopositive
immunoreactions were noticed in cytoplasm of cells in
the organs. But reaction was prominent in study group.
Immunopositive reaction was also observed in nucleus of the
some cells in Langerhans islets of pancreas. Similar CSR reac-
tion was noticed in hepatocytes and both proximal and distal
tubular epithelial cells of the kidney (Figures 3(a), 3(b), 3(c),
3(d), 3(e), and 3(f)). HIF-1α immunoreactions markedly
increased in the study group while the controls were negative.
Langerhans islets of pancreas exhibited markedly HIF-
1α immunopositive reactions. Slight immunoreaction was
detected in hepatocytes of the liver. Strong HIF-1α reaction
was observed in both proximal and distal tubular epithelial
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Figure 3: CSR reactions. (a) Severe expression in nucleus and cytoplasms of endocrine islets of pancreas in study group (arrows), Bar =
50 μm. (b) No immunoreaction in Langerhans islets of pancreas in control group, Bar = 100 μm. (c) Severe immunopositive reaction in
hepatocyte in study group (arrows), Bar = 100 μm. (d) A few immunoreactions in liver (arrows) in control group, Bar = 100 μm. (e) Strong
immunopositive reaction in tubular epithelial cells in kidney (arrows) in study group, Bar = 200 μm. (f) Very slight immunoreactions in
kidney in control group, Bar = 200 μm. ABC-P method with Hematoxyline counterstaining was used for all tissues. The right column
belongs to study group and left column belongs to control group.
cells of the kidney in study group (Figures 4(a), 4(b), 4(c),
4(d), 4(e), and 4(f)). Positive immunoreactivity was noted
by an intense brown color (DAB). All of the markers were
gradually increased related to days from induction of DM in
this study (Figures 5(a), 5(b), 5(c), 5(d), and 5(e)).
4. Discussion
STZ administration to mature rats induces severe and
permanent diabetes, with a decrease in insulin levels, to
produce a cytotoxic model of diabetes very similar to type I
DM. Streptozocin damages β cells of the islets of Langerhans
in the pancreas [16]. Streptozotocin-induced diabetes in the
rats is being employed extensively for studies into the immu-
nopathogenesis of DM [17]. Although several studies have
examined the underlying immune cellular and molecular
changes during disease in this model, investigations on the
early stages and cell injury in different organs have been
limited. Cell damage is the main reason of necrosis and
numerous agents can cause this process. The main reason of
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Figure 4: HIF reactions. (a) Severe expression in endocrine islets of pancreas in study group (arrows), Bar = 100 μm. (b) Slight
immunoreaction in Langerhans islets of pancreas in control group, Bar = 100 μm. (c) Severe immunopositive reaction in hepatocyte in
study group (arrows), Bar = 50 μm. (d) A few immunoreactions in liver in control group, Bar = 50 μm. (e) Strong immunopositive reaction
in tubular epithelial cells in kidney (arrows) in study group, Bar = 50 μm. (f) Very slight immunoreactions in kidney in control group, Bar
= 100 μm. ABC-P method with Hematoxyline counterstaining was used for all tissues. The right column belongs to study group and left
column belongs to control group.
cellular injury is hypoxia and it is commonly seen. Calcium
is main player of the cell damage and activates both plasma
membrane and mitochondrial injuries which are cell damage
pathways. COX enzymes play a major role in cellular damage
process. Cell death is the last stage of the cellular damage and
it can occur by apoptosis or necrosis. Caspase-3 is the main
marker of the apoptosis [18]. This study planned to examine
the role of calcium, hypoxia, and apoptosis in early stages of
DM in different cells by using HIF-1α, COX-1 and -2, CSR
and Caspase-3 by immunohistochemical method.
DM results from the progressive destruction of beta
cells of Langerhans islets [19]. Multiple mechanisms have
been proposed as effectors of beta cell destruction [20, 21].
Although DM is a chronic and progressive disease, initial
lesions can be seen in very early stages. Previous studies
reported that initial lesions occur after 3 days of DM
induction in rats [22, 23]. Similar findings were observed
in this study, and glucosuria was detected three days after
streptozotocin treatment. Tissue sections of pancreas, liver,
and kidney were examined histopathologically and immuno-
histochemically at 3rd, 4th, and 5th days. This study demon-
strated that increased expression of caspase-3, COX-1 and -2,
CSR, and HIF-1α in islet of Langerhans, liver, and kidney in
streptozotocin induced DM in rats. These results supported
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Figure 5: Statistical analysis results of (a) Caspase-3, (b) COX-1, (c) COX-2, (d) CSR, and (e) HIF-1αimmunopositive cell numbers.
the idea that cellular damages due to DM can occur in very
early stages of the disease. Our results showed that different
mechanisms may play role in diabetes like as hypoxia, apop-
tosis, and calcium influx in degenerative changes in cells.
Caspases are cysteine-aspartyl specific proteases that
play a key role in apoptosis [24]. Caspase-3 is one of the
effector caspases downstream of apoptotic pathways. Gene
targeting strategies have provided valuable tools to study
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the physiologic function of individual caspases in vivo and
have shown their roles not only in apoptosis but also in other
fundamental cellular processes [4]. Several in vitro studies
have suggested that caspase dependent apoptotic pathways
are essential for β cell apoptosis [25]. The underlying mech-
anism of tubular changes in kidney in diabetes, however,
is unclear. One attractive mechanism is apoptosis, which
has been demonstrated to mediate cell death in a variety of
renal diseases, including diabetic nephropathy [26]. Indeed,
apoptosis was detected in renal proximal tubular cells of
different species including experimental animals and patient
with diabetes, suggesting that tubular apoptosis may precede
tubular atrophy in diabetes [27, 28]. In this study, apoptotic
activity in pancreatic islets was also observed in the study
group’s rats and was an agreement with previous studies. At
the same time we also observed increased apoptotic activity
in the hepatocytes and kidney tubular cells. This study
showed that possible mechanism of occurrence of liver and
kidney problem in diabetes may be related to the increased
apoptotic activity.
Many studies using streptozotocin-induced type 1 dia-
betic rats have shown an increase in COX-2 production in
kidney [23]. Therefore, in the present study, the kidneys of
study and control rats were investigated histologically and
immunohistochemically, and changes in the renal expression
of COX-2 during the DM induction were marked in the
study group compared to control group. Marked increase
in COX-2 expressions was observed in the renal proximal
tubules and macula densa in the study group as compared
with the control group. Only slight increases were observed
in COX-1 expression in the study group. These results were
corresponding to previous observations [23]. The possible
cause of the increased COX-2 protein expression in kidneys
of study group rats may be related to that the tissue changes
also have a pathophysiological impact in modulating renal
hemodynamics in diabetes.
Calcium is known to be an important intracellular
messenger. Ca2+ plays a key role in numerous cellular
processes, such as maintaining membrane potential and
controlling hormonal secretion and cellular proliferation and
differentiation [8]. The mechanisms governing extracellular
calcium homeostasis maintain its near constancy to ensure
continual availability of calcium ions for their multiple
intra- and extracellular functions. CSR expression has an
important role in many physiological situations. It is involved
in calcium metabolism regulation in many cells such as
parathyroid [29], bone [30], kidney cells [31], fibroblasts
[32], antral gastrin cells [33], epithelial cells [34], oligoden-
drocytes [30], renal cells, retina, osteoclasts and osteoblasts,
vessels smooth muscle cells, and on some brain cells [8].
In this study CSR expression was demonstrated in pancreas,
liver, and kidney in diabetes-induced rats. Expression of the
CSR was more prominent in the study group than the control
group. Marked increase was observed in both nucleus and
cytoplasm of the cells of Langerhans islets of pancreas in the
study group. Little expression was seen in the control group
and only in cytoplasm. Strong immunopositive reaction
was observed in collective tubules of kidney compared to
the controls. Hepatocytes also expressed CSR in both groups,
and reaction was more prominent in the study group.
Hypoxia is the main regulator of HIF-1α expression and
function in some conditions such as diabetes pathogenesis
[35, 36]. HIF-1α is one of the important members of the
bHLH-PAS family [37] and functions as an obligate dimer
with other family members, including aryl hydrocarbon
receptor (AhR) nuclear translocator (ARNT) [38]. HIF-
1α degradation occurred by HIF prolyl hydroxylases. HIF-
1α degradation can be considered cellular oxygen sen-
sors, because their activity varies in the range of physio-
logic/pathologic oxygen tensions [39]. It is very important
to detect HIF activation in tissue sections by immunohisto-
chemical methods in detection of nuclear HIF-1α [40]. HIF
activity can be modulated by a number of factors such as
hydrogen peroxide and superoxide [41]. Diabetes can cause
increased production of reactive oxygen species [42]. In the
renal medulla, NAD(P)H oxidase activity can cause increased
superoxide in the thick ascending limbs of the loop of Henle
[43]. Superoxide may both intensify renal medullary hypoxia
and reduce hypoxia adaptation in diabetes [44]. In this study,
although HIF-1α-negative in the control group’s pancreas,
increase reaction was seen in the liver and kidney in the study
group. The most marked reaction of HIF-1α was observed in
Langerhans islets of the pancreas.
5. Conclusion
As a result, this study showed that marked immunoreaction
can be seen in the pancreas, liver and kidney with caspase-
3, COX-1, COX-2, CSR, and HIF-1α in diabetes-induced
rats. These reactions became prominent related to days after
induction. The possible cause of the increase may be related
to cellular damage by different routes. Increase of severity of
the immunoreactions related to days also supported this idea.
The most marked reaction was observed in Langerhans islets
of pancreas with all of the markers in this study. But liver,
and kidney can be affected in very early stages of the disease.
These results indicated that cellular damage in DM showed
both hypoxia and calcium influx in the cells. Apoptosis can
cause marked lesions in organs. This study showed that
although diabetes is a chronic disease, its affects can be seen
in cells in early stages.
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